Retrospective Analysis of Efficacy, Safety, Prognostic Parameters, and Quality of Life Factors in Topical Immunotherapy of Alopecia Areata with Diphenylcyclopropenone

    Florian Rasche
    Studysummary This study examines the use of diphenylcyclopropenone in treating alopecia areata patients at the University Hospital Würzburg and investigates how the treatment affects patients' quality of life.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on opus.bibliothek.uni-wuerzburg.de →
    Discuss this study in the Community →